Does Semaglutide Stop Your Period or Change Your Cycle?

What the STEP trials recorded, and what they didn't

The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults with obesity over 68 weeks and remains the definitive evidence base for semaglutide 2.4mg in weight management. It did not report menstrual disruption as a notable adverse event. That isn't evidence the effect doesn't happen, it reflects that reproductive-cycle outcomes were not a primary or pre-specified endpoint, and trials routinely undercount self-limiting symptoms that participants may not flag unless asked directly.

Post-marketing reports and survey data collected since Wegovy launched tell a more nuanced story. Many people describe irregular or skipped periods in the first weeks after starting treatment, particularly around or after dose increases. Because these reports are not from controlled trials, it is difficult to separate the effect of the medicine from the effect of losing weight quickly. If you want a direct answer to whether semaglutide stops periods altogether, the honest position is that it probably doesn't do so directly, but the weight loss it drives can, at least temporarily. You can read more about specific cycle changes, including late periods, on our page covering whether semaglutide can make your period late.

Why weight loss itself disrupts hormone balance

Body fat is not metabolically inert. Adipose tissue produces oestrogen, and the brain's reproductive axis (the hypothalamic-pituitary-ovarian pathway) is sensitive to energy availability and fat stores. When weight falls rapidly, oestrogen levels can shift, leptin signalling changes, and the regularity of ovulation can be affected. This is the same mechanism behind cycle disruption seen in athletes with very low body fat, or in people who lose weight quickly through any route.

Semaglutide can produce meaningful weight loss within weeks of reaching a therapeutic dose. For some people that drop is fast enough to affect their cycle before their body adapts. The semaglutide overview on our site explains how the medicine works and what the licensed dose schedule looks like, the starting dose is specifically calibrated to allow the body to adjust, which matters for tolerability beyond just the well-known gastrointestinal effects.

For most people, cycle changes are temporary. As weight stabilises and the body adjusts to its new hormonal environment, periods typically return to something closer to their previous pattern. But individual variation is wide, and there is no reliable way to predict in advance how any given person's cycle will respond.

The contraception question is practical and urgent

There is an important contraceptive consideration specific to tirzepatide (rather than semaglutide), but the broader point applies to anyone using a GLP-1 medicine for weight loss: as weight falls and hormonal balance shifts, fertility can improve, sometimes before a person realises it. Whether Wegovy stops your period is, in part, the wrong question if you are also wondering whether you might become pregnant; restored ovulation does not announce itself.

NHS England's guidance on weight-management injections advises using effective contraception throughout treatment. For semaglutide specifically, there is no current evidence that it reduces the effectiveness of the oral contraceptive pill in the way that tirzepatide can. Even so, if your cycle has become unpredictable, relying on cycle-tracking as contraception becomes unreliable. Keeping your pack of Wegovy in the fridge door alongside anything else you take in the morning is a practical way to anchor the habit, consistency with the medicine matters as much as the dose itself.

If you are planning to conceive, semaglutide is not recommended during pregnancy or while breastfeeding, and a wash-out period before trying to conceive is advised; your prescriber will guide you on timing. You can find more detail on how the medicine interacts with cycle timing on the page exploring semaglutide's effect on your period.

When to seek advice and what to tell your prescribing team

Missed or irregular periods while losing weight are common and usually not alarming. That said, some situations do need prompt attention. If you miss more than two consecutive periods, experience very heavy or prolonged bleeding, or have any symptoms that concern you, speak to a clinician. Severe abdominal pain should always be assessed urgently, the MHRA's Yellow Card reporting service exists for any suspected side effects you want to flag formally, and the NHS England guidance on weight-management injections covers what to monitor during treatment.

At nume, a real clinician reviews every consultation, and every repeat order. Questions about cycle changes, contraception, or how your treatment is affecting you are exactly the kind of thing our prescribers are here for. If you are weighing up treatment or want to talk through how semaglutide might fit your situation, you can speak to our prescribers through a free consultation, there is no obligation, and clinical suitability is always assessed first.